GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,604.50p
   
  • Change Today:
    -5.50p
  • 52 Week High: 1,812.50
  • 52 Week Low: 1,316.00
  • Currency: UK Pounds
  • Shares Issued: 4,144.96m
  • Volume: 4,229,876
  • Market Cap: £66,506m
  • RiskGrade: 129

GSK raises £1.25bn from sale of remaining Haleon stake

By Michele Maatouk

Date: Friday 17 May 2024

LONDON (ShareCast) - (Sharecast News) - GSK said on Friday that it has sold its remaining 4.2% stake in consumer health business Haleon, which it spun off in July 2022.
The pharmaceutical company sold just over 385m ordinary shares in Haleon at 324p each, raising gross proceeds of about £1.25bn.

GSK initially retained a 12.9% stake in Haleon, but had since sold stakes in May 2023, October 2023 and January 2024.

"GSK's exit of its position in Haleon is consistent with its previous commitments to monetise its holding in a disciplined manner," it said.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,604.50p
Change Today -5.50p
% Change -0.34 %
52 Week High 1,812.50
52 Week Low 1,316.00
Volume 4,229,876
Shares Issued 4,144.96m
Market Cap £66,506m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
54.34% below the market average54.34% below the market average54.34% below the market average54.34% below the market average54.34% below the market average
41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average
Price Trend
31.01% above the market average31.01% above the market average31.01% above the market average31.01% above the market average31.01% above the market average
47.17% above the sector average47.17% above the sector average47.17% above the sector average47.17% above the sector average47.17% above the sector average
Income
21.31% above the market average21.31% above the market average21.31% above the market average21.31% above the market average21.31% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
20.43% below the market average20.43% below the market average20.43% below the market average20.43% below the market average20.43% below the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

What The Brokers Say

Strong Buy 8
Buy 4
Neutral 10
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 16-May-24 22-Feb-24
Paid 11-Jul-24 11-Apr-24
Amount 15.00p 16.00p

Trades for 14-Jun-2024

Time Volume / Share Price
16:35 35,372 @ 1,604.50p
16:35 2,548 @ 1,604.50p
16:35 2,217,428 @ 1,604.50p
16:35 2,192 @ 1,604.50p
16:35 1,750 @ 1,604.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page